2004
Cities and Health: History, Approaches, and Key Questions
Vlahov D, Gibble E, Freudenberg N, Galea S. Cities and Health: History, Approaches, and Key Questions. Academic Medicine 2004, 79: 1133-1138. PMID: 15563646, DOI: 10.1097/00001888-200412000-00003.Chapters
1997
Design and Baseline Participant Characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: A Prospective Cohort Study of Human Immunodeficiency Virus Infection in US Women
Smith D, Warren D, Vlahov D, Schuman P, Stein M, Greenberg B, Holmberg S, Group F. Design and Baseline Participant Characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: A Prospective Cohort Study of Human Immunodeficiency Virus Infection in US Women. American Journal Of Epidemiology 1997, 146: 459-469. PMID: 9290506, DOI: 10.1093/oxfordjournals.aje.a009299.Peer-Reviewed Original ResearchConceptsUS womenHuman immunodeficiency virus (HIV) infectionPublic Health Service agenciesImmunodeficiency virus infectionProspective cohort studyInjection drug useHIV-infected womenBaseline participant characteristicsInpatient medical recordsHealth service agenciesSexual risk behaviorsUninfected womenHIV cohortCohort studyInfected womenHIV infectionPhysical examinationMedical recordsHIV epidemicLongitudinal cohortVirus infectionCare settingsHigh riskDrug useRisk behaviors
1991
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal Of Public Health 1991, 81: 1285-90. PMID: 1928527, PMCID: PMC1405342, DOI: 10.2105/ajph.81.10.1285.Peer-Reviewed Original ResearchConceptsIntravenous drug usersCD4 cell countDrug usersHealth servicesHIV serostatusClinical symptomsHIV-seropositive intravenous drug usersHealth insuranceCell countAsymptomatic HIV-1 infectionSeropositive intravenous drug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive drug usersOngoing natural history studyLow CD4 countHIV-1 seropositiveImmunodeficiency virus infectionHIV-1 serostatusHealth care utilizationHIV-1 infectionHIV-positive serostatusNatural history studiesHealth care servicesCD4 countMore HIV